Multi-System GLP-1 Pharmacology & Therapeutic Applications Review (PubMed, 2019) GLP-1s Pleiotropic Receptor Distribution Across Pancreas, Brain, Heart, and Gut A major review of GLP-1s multifaceted pharmacology published on PubMed confirmed GLP-1s broad pharmacological potential across multiple systems
Applying peptide protocols to children with eczema would be off-label to an extreme degree, and the developing immune system and skin barrier present additional unknowns
IGF-1 acts as an antinatriuretic in healthy subjects and in children with GHR-defects, suggesting that its sodium-retaining properties may be at least partly mediated by IGF-1 [59, 60]
Systemic subQ dosing at 0.52 mg is more likely to produce central effects than topical application
The adoption of GLP-1 drugs for weight loss is exerting noticeable pressure on the food industry, driving changes in consumer behavior and dietary preferences